abstract |
The present invention relates to selective androgen receptor modulators (SARMs) and / or analogs, derivatives, isomers, metabolites, pharmaceutically acceptable salts, pharmaceutical products, hydrates, N-oxides, or any combination thereof. 1) A method of treating a patient with near-consumable disorder; 2) methods of preventing myotropic disorders in patients; 3) methods of treating, preventing, inhibiting, inhibiting or reducing muscle loss in patients with myotropic disorders; 4) methods of treating, preventing, inhibiting, reducing or inhibiting small hair in patients with near-consumable disorders; And / or 5) a method of treating, preventing, inhibiting, reducing or inhibiting muscle protein catabolism in a patient with near-consumable disorder. |